Cellectar Biosciences Announces 1-For-20 Reverse Stock Split And Reduction In Authorized Shares Of Common Stock

MADISON, Wis., June 13, 2014 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (OTCQX:CLRB), announced a 1-for-20 reverse stock split of its common stock, effective at the close of business today, as a first step in a planned listing of its common stock on the NASDAQ Capital Market.

Help employers find you! Check out all the jobs and post your resume.